Impel Pharmaceuticals Inc.
IMPL · NASDAQ
9/30/2023 | 6/30/2023 | 3/31/2023 | 12/31/2022 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$14 | -$7 | -$30 | -$23 |
| Dep. & Amort. | $1 | -$0 | $0 | $0 |
| Deferred Tax | -$3 | -$12 | $0 | $0 |
| Stock-Based Comp. | $1 | $1 | $1 | $1 |
| Change in WC | -$5 | -$4 | -$1 | $0 |
| Other Non-Cash | $4 | $1 | $5 | $3 |
| Operating Cash Flow | -$17 | -$20 | -$24 | -$18 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$1 | $0 | -$1 | -$1 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | -$1 | $0 | -$1 | -$1 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $0 | $0 | $0 | -$0 |
| Stock Repurch. | $0 | $0 | $0 | -$0 |
| Dividends Paid | $0 | $0 | $0 | -$0 |
| Other Fin. Act. | $0 | $0 | $0 | -$0 |
| Financing Cash Flow | $7 | $0 | $0 | -$0 |
| Forex Effect | $11 | $21 | $0 | $0 |
| Net Chg. in Cash | -$10 | -$20 | -$25 | -$19 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $15 | $35 | $61 | $80 |
| End Cash | $5 | $15 | $35 | $61 |
| Free Cash Flow | -$17 | -$20 | -$25 | -$19 |